Cue生物製藥 CUE 深 滬
等待開盤 04-30 09:30:00 美东时间
13.00
+0.545
+4.38%
華盛通- 最 高13.00
- 今 開12.29
- 成交量 8.57万股
- 最 低 12.00
- 昨 收 12.455
- 總市值 4231.97万
- 52周最高 30.9696
- 市盈率 靜 --
- 換手率 2.63%
- 52周最低 4.971
- 委 比 -82.15%
- 總股本 325.54万
- 歷史最高 950.70
- 量 比 0.03
- 振 幅 8.03%
- 歷史最低 4.971
- 每 手 1
- 風險率 6.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Behind The Drop In Cue Biopharma Stock Today?
Cue Biopharma, Inc. (NASDAQ:CUE) shares are tumbling on Wednesday after the company announced a reverse stock split.
04-23 00:23
Cue Biopharma shares are trading lower after the company announced a 1-for-30 reverse stock split.
Cue Biopharma shares are trading lower after the company announced a 1-for-30 r...
04-22 21:02
Cue Biopharma implements 1-for-30 reverse stock split
Cue Biopharma implements 1-for-30 reverse stock split Cue Biopharma will implement a 1-for-30 reverse stock split effective 5:00 p.m. ET April 23, 2026. Shares are expected to begin trading on a split-adjusted basis April 24, 2026 under ticker CUE. Move targets higher per-share price to regain compl
04-22 20:37
Cue Biopharma Shareholders Approve Reverse Stock Split Flexibility
Cue Biopharma ( ($CUE) ) has shared an announcement. At its April 13, 2026 annu...
04-14 04:47
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galmed Pharmaceuticals (NASDAQ:GLMD) stock increased by 83.2% to $1.14...
04-09 20:05
Why GameSquare Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
GAME stock rose 52.3% in pre-market trading after reporting positive EBITDA and financials. Other gainers include PMAX, DKI, ARAI, JTAI, YMT, STAA, ALBT, MRLN, SWMR. Losers include HCAI, HUBC, AIXI, CUE, and OMEX.
04-09 17:24
Cue Biopharma Reaches Key Preclinical Milestone With Boehringer
Cue Biopharma ( ($CUE) ) has shared an announcement. On April 1, 2026, Cue Biop...
04-07 20:58
Cue Biopharma Names Lucinda Warren Interim Chief Executive
The latest announcement is out from Cue Biopharma ( ($CUE) ). On March 26, 2026...
03-28 04:49
Cue Biopharma President, CEO Usman Azam Steps Down, Effective March 26; Lucinda Warren Named Interim President, CEO
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of
03-28 04:06
